Previous 10 | Next 10 |
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Twist To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - December 13, 2022) - Faruqi & Faruqi, LLP, a leading national securities law firm, i...
NEW YORK, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against PROG Holdings, Inc. (NYSE: PRG), Fox Corporation (NASDAQ: FOX, FOXA), Instil Bio, Inc. (NASDAQ: TIL), and Twist Bioscience Co...
SAN FRANCISCO, CA / ACCESSWIRE / December 8, 2022 / Hagens Berman urges Twist Bioscience Corporation (NASDAQ:TWST) investors who suffered significant losses to submit your losses now . Visit: www.hbsslaw.com/investor-fraud/TWST Contact An Attorney Now: TWST@hbsslaw.com 844-916-089...
San Francisco, California--(Newsfile Corp. - December 1, 2022) - Hagens Berman urges Twist Bioscience Corporation (NASDAQ: TWST) investors who suffered significant losses to submit your losses now . Visit: www.hbsslaw.com/investor-fraud/TWST Contact An Attorney Now: TWST@hbsslaw.c...
NEW YORK, NY / ACCESSWIRE / November 25, 2022 / Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Twist Bioscience Corporation ("Twist" or the "Company") (NASDAQ:TWST). If you suffered losses exceeding $50,000 investing in Twist sto...
Company to host investors at the Factory of the Future on November 29 Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily M. Leproust, Ph.D....
-- Record revenue of $203.6 million in Fiscal 2022; Increase of 54% over $132.3 million in Fiscal 2021 – -- Orders increased to $226 million in Fiscal 2022; Increase of 42% over $160 million in Fiscal 2021 -- — Expect revenue in the range of $261 million to $269 mi...
Shares of Twist Bioscience (NASDAQ: TWST) were crashing this week, plunging 37.2% as of the market close on Thursday, according to data provided by S&P Global Market Intelligence . The steep decline came after Scorpion Capital announced on Tuesday that it was short-selling t...
A day after synthetic biology and genomics company Twist Bioscience (NASDAQ: TWST) saw its shares rise 16.1%, they did a U-turn, falling 19.92% on Tuesday. The stock nearly matched its 52-week low and is a long way from its 52-week high. A report issued Tuesday by Scorpion Capit...
Twist to report fiscal Q4 and full year 2022 financial results before market Friday, November 18, and host a conference call at 8:00 a.m. Eastern Time Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-qualit...
News, Short Squeeze, Breakout and More Instantly...
Twist Bioscience Corporation Company Name:
TWST Stock Symbol:
NASDAQ Market:
Twist Bioscience Corporation Website:
Pure Biologics’ exploratory Phase 0 study to evaluate pharmacodynamic activity of PBA-0405 in solid tumors Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today a...
Company to host conference call at 8:00 AM ET Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will issue its financial results for the fiscal 2024 th...
Express Genes enable faster turnaround times Twist Express Antibodies, CHO starting at 13 business days Twist Express Antibodies, HEK293 starting at 10 business days Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of ...